Kirstin Finning

1.5k total citations
22 papers, 1.1k citations indexed

About

Kirstin Finning is a scholar working on Hematology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Kirstin Finning has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 18 papers in Pediatrics, Perinatology and Child Health and 14 papers in Infectious Diseases. Recurrent topics in Kirstin Finning's work include Blood groups and transfusion (19 papers), Prenatal Screening and Diagnostics (18 papers) and Parvovirus B19 Infection Studies (14 papers). Kirstin Finning is often cited by papers focused on Blood groups and transfusion (19 papers), Prenatal Screening and Diagnostics (18 papers) and Parvovirus B19 Infection Studies (14 papers). Kirstin Finning collaborates with scholars based in United Kingdom, Switzerland and Italy. Kirstin Finning's co-authors include Geoff Daniels, Peter Martin, Pete Martin, Edwin Massey, Lyn S. Chitty, Neil D. Avent, Deborah G. Maddocks, Jon Hyett, S. J. Urbaniak and Glenn Gardener and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and American Journal of Obstetrics and Gynecology.

In The Last Decade

Kirstin Finning

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kirstin Finning United Kingdom 17 857 601 570 175 124 22 1.1k
Frederik Banch Clausen Denmark 17 632 0.7× 523 0.9× 380 0.7× 125 0.7× 111 0.9× 54 866
K. Finning United Kingdom 12 629 0.7× 376 0.6× 403 0.7× 94 0.5× 116 0.9× 16 774
Deborah G. Maddocks United Kingdom 12 544 0.6× 169 0.3× 214 0.4× 82 0.5× 193 1.6× 13 742
Aïcha Ait Soussan Netherlands 12 323 0.4× 307 0.5× 219 0.4× 63 0.4× 73 0.6× 19 510
Ageliki Gerovassili United Kingdom 7 649 0.8× 88 0.1× 233 0.4× 14 0.1× 254 2.0× 8 775
Vach Angkachatchai United States 7 556 0.6× 60 0.1× 234 0.4× 9 0.1× 151 1.2× 10 706
F Agostinelli Italy 9 295 0.3× 579 1.0× 105 0.2× 68 0.4× 104 0.8× 23 832
M Manna Italy 9 182 0.2× 394 0.7× 70 0.1× 57 0.3× 100 0.8× 18 604
Yuqiu Zhou China 10 143 0.2× 260 0.4× 32 0.1× 53 0.3× 103 0.8× 30 495
Manuela Testi Italy 13 102 0.1× 241 0.4× 55 0.1× 18 0.1× 67 0.5× 23 479

Countries citing papers authored by Kirstin Finning

Since Specialization
Citations

This map shows the geographic impact of Kirstin Finning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirstin Finning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirstin Finning more than expected).

Fields of papers citing papers by Kirstin Finning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirstin Finning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirstin Finning. The network helps show where Kirstin Finning may publish in the future.

Co-authorship network of co-authors of Kirstin Finning

This figure shows the co-authorship network connecting the top 25 collaborators of Kirstin Finning. A scholar is included among the top collaborators of Kirstin Finning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirstin Finning. Kirstin Finning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Regan, Fiona, Janet Brennand, Edwin Massey, et al.. (2025). Guideline for the investigation and management of red cell antibodies in pregnancy: A British Society for Haematology guideline. Transfusion Medicine. 35(1). 3–23. 3 indexed citations
2.
3.
Chitty, Lyn S., Kirstin Finning, Angela Wade, et al.. (2015). Diagnostic Accuracy of Routine Antenatal Determination of Fetal RHD Status Across Gestation. Obstetrical & Gynecological Survey. 70(1). 5–7. 2 indexed citations
4.
Akolekar, Ranjit, et al.. (2011). Fetal <i>RHD</i> Genotyping in Maternal Plasma at 11–13 Weeks of Gestation. Fetal Diagnosis and Therapy. 29(4). 301–306. 41 indexed citations
5.
Daniels, Geoff, Kirstin Finning, & Pete Martin. (2010). Noninvasive Fetal Blood Grouping: Present and Future. Clinics in Laboratory Medicine. 30(2). 431–442. 16 indexed citations
6.
Finning, Kirstin, Pete Martin, & Geoff Daniels. (2009). The Use of Maternal Plasma for Prenatal RhD Blood Group Genotyping. Methods in molecular biology. 496. 143–157. 16 indexed citations
7.
Li, Ying, Kirstin Finning, Geoff Daniels, et al.. (2008). Noninvasive genotyping fetal Kell blood group (KEL1) using cell‐free fetal DNA in maternal plasma by MALDI‐TOF mass spectrometry. Prenatal Diagnosis. 28(3). 203–208. 37 indexed citations
9.
Daniels, Geoff, Kirstin Finning, Pete Martin, & Edwin Massey. (2008). Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenatal Diagnosis. 29(2). 101–107. 103 indexed citations
10.
Finning, Kirstin, et al.. (2008). Effect of High Throughput RHD Typing of Fetal DNA in Maternal Plasma on Use of Anti-RhD Immunoglobulin in RhD Negative Pregnant Women: Prospective Feasibility Study. Obstetrical & Gynecological Survey. 63(8). 499–500. 13 indexed citations
11.
Finning, Kirstin & Lyn S. Chitty. (2008). Non-invasive fetal sex determination: Impact on clinical practice. Seminars in Fetal and Neonatal Medicine. 13(2). 69–75. 72 indexed citations
12.
Finning, Kirstin, et al.. (2007). Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell‐free fetal DNA in maternal plasma. Transfusion. 47(11). 2126–2133. 98 indexed citations
13.
Legler, Tobias J., Zhong Liu, Ariadni Mavrou, et al.. (2007). Workshop report on the extraction of foetal DNA from maternal plasma. Prenatal Diagnosis. 27(9). 824–829. 93 indexed citations
14.
Daniels, Geoff, et al.. (2006). Fetal Blood Group Genotyping. Annals of the New York Academy of Sciences. 1075(1). 88–95. 32 indexed citations
15.
Poole, Joyce, Hein Hustinx, Behrouz Mansouri Taleghani, et al.. (2006). A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen. Transfusion. 46(11). 1879–1885. 16 indexed citations
16.
Hyett, Jon, Glenn Gardener, Kirstin Finning, et al.. (2005). Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenatal Diagnosis. 25(12). 1111–1116. 84 indexed citations
17.
Clausen, Frederik Banch, Grethe Risum Krog, Klaus Rieneck, et al.. (2005). Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenatal Diagnosis. 25(11). 1040–1044. 39 indexed citations
18.
Finning, Kirstin, Peter Martin, & Geoff Daniels. (2004). A Clinical Service in the UK to Predict Fetal Rh (Rhesus) D Blood Group Using Free Fetal DNA in Maternal Plasma. Annals of the New York Academy of Sciences. 1022(1). 119–123. 87 indexed citations
19.
Finning, Kirstin, et al.. (2004). Use of maternal plasma for noninvasive determination of fetal RhD status. American Journal of Obstetrics and Gynecology. 191(5). 1730–1732. 16 indexed citations
20.
Avent, Neil D., Kirstin Finning, Peter Martin, & Peter Soothill. (2000). Prenatal Determination of Fetal Blood Group Status. Vox Sanguinis. 78(S2). 155–162. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026